NASDAQ:AHCO AdaptHealth (AHCO) Stock Price, News & Analysis → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free AHCO Stock Alerts $9.58 -0.20 (-2.04%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$9.51▼$9.8050-Day Range$7.10▼$11.5152-Week Range$6.37▼$15.37Volume469,020 shsAverage Volume1.08 million shsMarket Capitalization$1.27 billionP/E RatioN/ADividend YieldN/APrice Target$12.10 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get AdaptHealth alerts: Email Address AdaptHealth MarketRank™ Stock AnalysisAnalyst RatingHold2.29 Rating ScoreUpside/Downside26.3% Upside$12.10 Price TargetShort InterestHealthy10.32% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.60Based on 4 Articles This WeekInsider TradingSelling Shares$2.59 M Sold Last QuarterProj. Earnings Growth27.27%From $0.88 to $1.12 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.20 out of 5 starsMedical Sector344th out of 907 stocksHome Health Care Services Industry6th out of 8 stocks 3.1 Analyst's Opinion Consensus RatingAdaptHealth has received a consensus rating of Hold. The company's average rating score is 2.29, and is based on 3 buy ratings, 3 hold ratings, and 1 sell rating.Amount of Analyst CoverageAdaptHealth has only been the subject of 3 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted10.32% of the float of AdaptHealth has been sold short.Short Interest Ratio / Days to CoverAdaptHealth has a short interest ratio ("days to cover") of 6.4.Change versus previous monthShort interest in AdaptHealth has recently decreased by 11.45%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldAdaptHealth does not currently pay a dividend.Dividend GrowthAdaptHealth does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AHCO. Previous Next 2.6 News and Social Media Coverage News SentimentAdaptHealth has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.41 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for AdaptHealth this week, compared to 3 articles on an average week.MarketBeat FollowsOnly 4 people have added AdaptHealth to their MarketBeat watchlist in the last 30 days. This is a decrease of -71% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, AdaptHealth insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,586,012.00 in company stock.Percentage Held by Insiders13.60% of the stock of AdaptHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions82.67% of the stock of AdaptHealth is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.8 Earnings and Valuation Earnings GrowthEarnings for AdaptHealth are expected to grow by 27.27% in the coming year, from $0.88 to $1.12 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of AdaptHealth is -1.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of AdaptHealth is -1.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioAdaptHealth has a PEG Ratio of 0.64. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioAdaptHealth has a P/B Ratio of 0.87. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. About AdaptHealth Stock (NASDAQ:AHCO)AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.Read More AHCO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AHCO Stock News HeadlinesApril 23, 2024 | msn.comAdaptHealth Names Suzanne Foster as New CEO, Aiming to Strengthen Its Market PositionApril 22, 2024 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Inspire Medical Systems (INSP) and AdaptHealth (AHCO)April 25, 2024 | Stansberry Research (Ad)Mysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.April 20, 2024 | americanbankingnews.comAdaptHealth (NASDAQ:AHCO) Shares Gap Up to $9.43April 18, 2024 | businesswire.comAdaptHealth Corp. Announces First Quarter 2024 Earnings Release Date and Conference CallApril 17, 2024 | fool.comWhy Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth SankApril 17, 2024 | fool.comWhy Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth SankApril 17, 2024 | businesswire.comAdaptHealth Appoints Suzanne Foster as Chief Executive OfficerApril 25, 2024 | Stansberry Research (Ad)Mysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.April 11, 2024 | businesswire.comRobbins Geller Rudman & Dowd LLP Announces Proposed Settlement in the AdaptHealth Securities LitigationApril 10, 2024 | markets.businessinsider.comAdaptHealth Poised for Growth: Strong Buy Rating Affirmed Amid Positive Outlook and Strategic Financial ManagementApril 9, 2024 | msn.comUpcoming Deadline to Share in AdaptHealth Corp. (AHCO) Class Action SettlementMarch 11, 2024 | ca.finance.yahoo.comASND Jan 2025 120.000 callMarch 4, 2024 | markets.businessinsider.comPeeling Back The Layers: Exploring AdaptHealth Through Analyst InsightsMarch 4, 2024 | finance.yahoo.comAdaptHealth Corp. to Participate in the Barclays 26th Annual Global Healthcare ConferenceMarch 1, 2024 | finance.yahoo.comAdaptHealth Corp. to Participate in the 3rd Annual Jefferies Value Based Care SummitFebruary 29, 2024 | seekingalpha.comAdaptHealth Corp. (AHCO) Q4 2023 Earnings Call TranscriptFebruary 28, 2024 | finance.yahoo.comAdaptHealth Corp. (AHCO)February 28, 2024 | markets.businessinsider.comMaintaining Sell Rating on AdaptHealth Amid Forward Guidance Concerns and Growth HeadwindsFebruary 28, 2024 | finance.yahoo.comAdaptHealth Corp. (NASDAQ:AHCO) Q4 2023 Earnings Call TranscriptFebruary 28, 2024 | finance.yahoo.comAdaptHealth Full Year 2023 Earnings: Revenues Beat Expectations, EPS LagsFebruary 27, 2024 | markets.businessinsider.comAdaptHealth Corp Gains 28% Despite Increased Loss In Q4February 27, 2024 | fool.comWhy AdaptHealth Stock Is Skyrocketing TodayFebruary 27, 2024 | msn.comAdaptHealth GAAP EPS of -$1.91 misses by $2.07, revenue of $858.2M beats by $32.75MFebruary 27, 2024 | finance.yahoo.comAdaptHealth Corp (AHCO) Reports Solid Revenue Growth Amidst Net Loss Due to Goodwill Write-DownFebruary 27, 2024 | finance.yahoo.comAdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 OutlookFebruary 27, 2024 | businesswire.comAdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 OutlookSee More Headlines Receive AHCO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AdaptHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/27/2024Today4/25/2024Next Earnings (Confirmed)5/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Home health care services Sub-IndustryN/A Current SymbolNASDAQ:AHCO CUSIPN/A CIK1725255 Webwww.adapthealth.com Phone(610) 424-4515FaxN/AEmployees10,700Year FoundedN/APrice Target and Rating Average Stock Price Target$12.10 High Stock Price Target$21.00 Low Stock Price Target$6.50 Potential Upside/Downside+23.7%Consensus RatingHold Rating Score (0-4)2.29 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($5.31) Trailing P/E RatioN/A Forward P/E Ratio11.11 P/E Growth0.64Net Income$-678,900,000.00 Net Margins-21.21% Pretax Margin-22.62% Return on Equity8.84% Return on Assets3.39% Debt Debt-to-Equity Ratio1.44 Current Ratio1.21 Quick Ratio1.00 Sales & Book Value Annual Sales$3.20 billion Price / Sales0.41 Cash Flow$10.40 per share Price / Cash Flow0.94 Book Value$11.06 per share Price / Book0.88Miscellaneous Outstanding Shares132,910,000Free Float114,832,000Market Cap$1.30 billion OptionableOptionable Beta1.02 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Richard Alan Barasch (Age 70)Chairman of the Board & Interim CEO Comp: $102.5kMr. Joshua Parnes (Age 45)President & Director Comp: $1.04MMr. Jason A. Clemens C.F.A. (Age 45)Chief Financial Officer Comp: $870.2kMr. Albert A. Prast (Age 64)Chief Technology Officer Comp: $738.03kMr. Christopher J. Joyce (Age 60)Secretary Comp: $790.71kMr. Shaw A. Rietkerk (Age 49)Chief Operating Officer Comp: $488.56kMs. Christie E. ArchboldChief Accounting OfficerAnton HieVice President of Investor RelationsMs. Wendy RussalesiChief Compliance OfficerMr. Jonathan B. Bush (Age 54)General Counsel More ExecutivesKey CompetitorsAddus HomeCareNASDAQ:ADUSBrightSpring Health ServicesNASDAQ:BTSGEnhabitNYSE:EHABAveanna HealthcareNASDAQ:AVAHAmedisysNASDAQ:AMEDView All CompetitorsInsiders & InstitutionsSimplicity Wealth LLCBought 34,640 shares on 4/24/2024Ownership: 0.026%Counterpoint Mutual Funds LLCSold 2,865 shares on 4/15/2024Ownership: 0.009%Inspirion Wealth Advisors LLCBought 30,000 shares on 4/13/2024Ownership: 0.092%GAMMA Investing LLCBought 1,683 shares on 4/5/2024Ownership: 0.002%Reinhart Partners LLC.Bought 144,516 shares on 4/3/2024Ownership: 3.168%View All Insider TransactionsView All Institutional Transactions AHCO Stock Analysis - Frequently Asked Questions Should I buy or sell AdaptHealth stock right now? 7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AdaptHealth in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" AHCO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AHCO, but not buy additional shares or sell existing shares. View AHCO analyst ratings or view top-rated stocks. What is AdaptHealth's stock price target for 2024? 7 analysts have issued 1-year price objectives for AdaptHealth's shares. Their AHCO share price targets range from $6.50 to $21.00. On average, they predict the company's share price to reach $12.10 in the next year. This suggests a possible upside of 26.3% from the stock's current price. View analysts price targets for AHCO or view top-rated stocks among Wall Street analysts. How have AHCO shares performed in 2024? AdaptHealth's stock was trading at $7.29 at the beginning of the year. Since then, AHCO stock has increased by 31.4% and is now trading at $9.58. View the best growth stocks for 2024 here. Are investors shorting AdaptHealth? AdaptHealth saw a decline in short interest in the month of April. As of April 15th, there was short interest totaling 7,270,000 shares, a decline of 11.4% from the March 31st total of 8,210,000 shares. Based on an average daily trading volume, of 1,140,000 shares, the days-to-cover ratio is presently 6.4 days. Approximately 10.3% of the company's stock are short sold. View AdaptHealth's Short Interest. When is AdaptHealth's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024. View our AHCO earnings forecast. How can I listen to AdaptHealth's earnings call? AdaptHealth will be holding an earnings conference call on Tuesday, May 7th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 785-424-1789 with passcode "AHCOFIRST". How were AdaptHealth's earnings last quarter? AdaptHealth Corp. (NASDAQ:AHCO) posted its quarterly earnings results on Tuesday, February, 27th. The company reported $0.64 EPS for the quarter, topping the consensus estimate of $0.20 by $0.44. The company earned $858.23 million during the quarter, compared to analyst estimates of $825.94 million. AdaptHealth had a positive trailing twelve-month return on equity of 8.84% and a negative net margin of 21.21%. What ETFs hold AdaptHealth's stock? ETFs with the largest weight of AdaptHealth (NASDAQ:AHCO) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), Invesco S&P SmallCap 600 Pure Value ETF (RZV), Harbor Small Cap Explorer ETF (QWST) and Invesco S&P SmallCap Health Care ETF (PSCH).Invesco FTSE RAFI US 1500 Small-Mid ETF (PRFZ). What guidance has AdaptHealth issued on next quarter's earnings? AdaptHealth issued an update on its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $3.3 billion-$3.4 billion, compared to the consensus revenue estimate of $3.3 billion. What other stocks do shareholders of AdaptHealth own? Based on aggregate information from My MarketBeat watchlists, some companies that other AdaptHealth investors own include Advanced Micro Devices (AMD), Johnson & Johnson (JNJ), Advance Auto Parts (AAP), American International Group (AIG), Biogen (BIIB), BioMarin Pharmaceutical (BMRN), Bristol-Myers Squibb (BMY), Caterpillar (CAT), Cisco Systems (CSCO) and CVS Health (CVS). Who are AdaptHealth's major shareholders? AdaptHealth's stock is owned by a variety of institutional and retail investors. Top institutional investors include Reinhart Partners LLC. (3.17%), Inspirion Wealth Advisors LLC (0.09%), Simplicity Wealth LLC (0.03%), Counterpoint Mutual Funds LLC (0.01%) and GAMMA Investing LLC (0.00%). Insiders that own company stock include Aero Holdings Ii Ll Skyknight, Alan G Quasha, Albert A Prast, Christopher J Joyce, Daniel Bunting, David Solomon Williams III, Everest Hill Group Inc, Frank Mullen, James E Flynn, Jason A Clemens, Ronald T Mcdaniel, Shaw Rietkerk, Skyknight Aero Holdings, Llc, Skyknight Capital Fund Ii, LP and Stephen P Griggs. View institutional ownership trends. How do I buy shares of AdaptHealth? Shares of AHCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:AHCO) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdaptHealth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
